Bharat Biotech - Organiser

Bharat Biotech

Professor Jamie Triccas Deputy Director at Sydney ID and Dr Krishna Ella EC at Bharat Biotech International Limited (Source: Bharat Biotech)

Bharat Biotech forge strategic partnership with University of Sydney for vaccine research

On Republic Day, Bharat Biotech launches first India-made nasal Covid Vaccine

Fake News: Govt rejects fake news reports that regulatory approval for Covaxin rushed due to Political Pressure

Clinical phase III trials of the Bharat Biotech’s COVID-19 nasal vaccine completed

COVAXIN

Covaxin safe for children aged 2-18 years, says Bharat Biotech

Covaxin booster shot enhances efficacy against Delta, Omicron variants of COVID-19: Study

COVAXIN

Germany to recognise Bharat Biotech’s COVAXIN for travel from June 1

CEPI partners with Bharat Biotech, University of Sydney, ExcellGene to develop ‘variant-proof’ COVID-19 vaccine

COVAXIN

Bharat Biotech seeks DCGI’s permission to conduct Covaxin booster trials in the 2-18 age group

Representative Image

India’s expanding COVID-19 vaccination programme set to achieve new milestones

Representative Image

DCGI grants EUA to ZycovD COVID vaccine for a two-dose regimen for children above 12

Representative Image

DCGI gives emergency use authorisation to Covaxin for the 6-12 age group

The 32-minute programme barely mentioned that it was paid content by the Telangana government (Photo Source: YouTube)

NDTV Broadcasts a 32-Minute Paid Content About Telangana Govt Disguised as News

COVAXIN

Japan recognises India’s COVAXIN to facilitate travel between both countries